Current evidence on uterine embolization for fibroids

Area of Science:

• Interventional Radiology
• Gynecology
• Vascular Surgery

Background:

• Uterine fibroids are common benign tumors affecting women of reproductive age.
• Uterine fibroid embolization (UFE) is a minimally invasive procedure for treating symptomatic fibroids.
• Growing evidence supports the safety and efficacy of UFE.

Purpose of the Study:

• To review the best available evidence on the outcomes of uterine fibroid embolization.
• To assess symptom relief and quality of life improvements following UFE.
• To compare UFE outcomes with traditional surgical fibroid treatments.
• To evaluate the durability of UFE's long-term effects.

Main Methods:

• Systematic review of key literature on uterine fibroid embolization.
• Analysis of studies reporting symptom severity and quality of life metrics.
• Comparative analysis of UFE versus surgical interventions (e.g., hysterectomy, myomectomy).
• Assessment of long-term follow-up data for symptom recurrence and patient satisfaction.

Main Results:

• UFE demonstrates significant effectiveness in relieving fibroid-related symptoms such as heavy menstrual bleeding and pelvic pain.
• Quality of life improvements post-UFE are comparable to those achieved with hysterectomy and myomectomy.
• Studies indicate durable symptom relief and sustained quality of life improvements for many years after UFE.
• UFE is associated with a favorable safety profile and shorter recovery times compared to open surgical procedures.

Conclusions:

• Uterine fibroid embolization is a safe and effective treatment option for symptomatic uterine fibroids.
• UFE offers comparable symptom relief and quality of life benefits to surgical alternatives.
• The positive outcomes of UFE are durable, providing long-term relief for patients.